RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill’s RHB-106 Encapsulated Bowel Preparation

RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill’s RHB-106 Encapsulated Bowel Preparation

[GlobeNewswire] – TEL-AVIV, Israel — Salix Pharmaceuticals Ltd. and RedHill Biopharma Ltd. today announced that they have entered into an exclusive agreement by which Salix has licensed the worldwide exclusive rights to … more

View todays social media effects on RDHL

View the latest stocks trending across Twitter. Click to view dashboard

See who Redhill is hiring next, click here to view

Share this post